IE
BBNX

Israel Englander’s Beta Bionics BBNX Stock Holding History

Israel Englander’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
956,244
+95,378
+11% +$1.13M 0.01% 1891
2026
Q1 		$8.63M Sell
860,866
-84,595
-9% -$1.25M ﹤0.01% 2318
2025
Q4 		$28.8M Buy
945,461
+148,497
+19% +$3.97M 0.01% 1219
2025
Q3 		$15.8M Buy
796,964
+254,766
+47% +$4.48M 0.01% 1925
2025
Q2 		$7.89M Buy
+542,198
New +$7.68M ﹤0.01% 2513

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Israel Englander's BBNX Position: Q2 2026 in Review

Israel Englander increased its Beta Bionics (BBNX) stake by 11% in Q2 2026, buying an estimated $1.13M and bringing the position to 956,244 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #1891.

Israel Englander first reported a position in BBNX in Q2 2025 and has held it in 5 quarters since. The position peaked at $28.8M in Q4 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Israel Englander held 956,244 shares of Beta Bionics worth $15M as of Q2 2026.
  • Israel Englander bought 95,378 Beta Bionics shares in Q2 2026, an estimated $1.13M.
  • Beta Bionics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1891 holding.
  • Israel Englander first reported a position in Beta Bionics in Q2 2025 and has held it in 5 quarters since.
  • Israel Englander's Beta Bionics position peaked at $28.8M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.